SHORT MINI-FUTURE - BRISTOL-MYERS SQUIBB | Market Closed - Börse Stuttgart 20:41:42 28/06/2024 BST | ||
| 4.85 EUR | 0.00% |
|
| Current month | +0.21% | ||
| 1 month | -0.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 4.85 | 0.00% |
| 27/06/24 | 4.85 | +1.68% |
| 26/06/24 | 4.77 | -0.42% |
| 25/06/24 | 4.79 | +0.21% |
| 24/06/24 | 4.78 | -1.04% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 08:41 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VV39WQ |
| ISIN | DE000VV39WQ5 |
| Date issued | 28/06/2022 |
| Strike | 93.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.59 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.96 € |
|---|---|
| Lowest since issue | 1.29 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.53
USD
Average target price
53.19
USD
Spread / Average Target
+28.09%
- Stock Market
- Certificates
- Certificat
